AAPL 171.29 -4.1305% MSFT 429.37 0.9736% GOOG 148.74 -0.628% GOOGL 147.6 -0.7664% AMZN 178.15 0.0% NVDA 914.35 1.1762% META 507.76 0.4431% TSLA 172.82 -1.6168% TSM 139.45 1.9744% LLY 770.26 -0.3364% V 290.37 0.3768% AVGO 1348.0 5.6426% JPM 199.06 1.3905% UNH 491.69 -0.5139% NVO 129.83 -0.4066% WMT 61.45 0.3265% LVMUY 182.95 -1.8193% XOM 113.49 0.4425% LVMHF 913.224 -2.0146% MA 488.64 0.1229%
Last update at 2024-03-21T20:10:00Z
Breakdown | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
---|---|---|---|---|---|
Type | yearly | yearly | yearly | yearly | yearly |
Date | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
Income before tax | 5628.00M | 10420.00M | 9770.00M | 8997.00M | 1406.00M |
Minority interest | 16.00M | -12.00000M | 13.00M | -3.00000M | -2.00000M |
Net income | 4311.00M | 7910.00M | 7179.00M | 6634.00M | -594.00000M |
Selling general administrative | 745.00M | 36934.00M | 35072.00M | 33061.00M | 21368.00M |
Selling and marketing expenses | - | - | - | - | - |
Gross profit | 54294.00M | 52048.00M | 49046.00M | 45528.00M | 31538.00M |
Reconciled depreciation | 4247.00M | 4512.00M | 4441.00M | 4371.00M | 2718.00M |
Ebit | 16251.00M | 13193.00M | 13911.00M | 11987.00M | 10174.00M |
Ebitda | 20498.00M | 19676.00M | 18558.00M | 16482.00M | 12892.00M |
Depreciation and amortization | 4247.00M | 6483.00M | 4647.00M | 4495.00M | 2718.00M |
Non operating income net other | 169.00M | -270.00000M | -1234.00000M | 45.00M | 4.00M |
Operating income | 16251.00M | 13193.00M | 13911.00M | 11987.00M | 4021.00M |
Other operating expenses | 306385.00M | 277129.00M | 254795.00M | 244789.00M | 184409.00M |
Interest expense | 2287.00M | 2503.00M | 2907.00M | 3035.00M | 2619.00M |
Tax provision | 1463.00M | 2522.00M | 2569.00M | 2366.00M | 2002.00M |
Interest income | 2287.00M | 2503.00M | 2907.00M | 3035.00M | 2619.00M |
Net interest income | -2287.00000M | -2503.00000M | -2907.00000M | -3035.00000M | -2619.00000M |
Extraordinary items | 0.00000M | 0.00000M | -9.00000M | 0.00000M | 100.00M |
Non recurring | 8336.00M | 431.00M | - | - | 6149.00M |
Other items | - | - | - | - | - |
Income tax expense | 1463.00M | 2522.00M | 2569.00M | 2366.00M | 2002.00M |
Total revenue | 322467.00M | 292111.00M | 268706.00M | 256776.00M | 194579.00M |
Total operating expenses | 38212.00M | 37066.00M | 35135.00M | 33541.00M | 21368.00M |
Cost of revenue | 268173.00M | 240063.00M | 219660.00M | 211248.00M | 163041.00M |
Total other income expense net | -10623.00000M | -2773.00000M | -4141.00000M | -2990.00000M | -6145.00000M |
Discontinued operations | - | - | -9.00000M | -9.00000M | -9.00000M |
Net income from continuing ops | 4165.00M | 7898.00M | 7201.00M | 6631.00M | -596.00000M |
Net income applicable to common shares | 4149.00M | 7910.00M | 7179.00M | 6634.00M | -594.00000M |
Preferred stock and other adjustments | - | - | - | - | - |
Breakdown | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
---|---|---|---|---|---|
Type | yearly | yearly | yearly | yearly | yearly |
Date | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
Total assets | 228275.00M | 232999.00M | 230715.00M | 222449.00M | 196456.00M |
Intangible assets | 24754.00M | 29026.00M | 31142.00M | 33121.00M | 36524.00M |
Earning assets | - | - | - | - | - |
Other current assets | 2685.00M | 5292.00M | 5277.00M | 5113.00M | 4581.00M |
Total liab | 156960.00M | 157618.00M | 161014.00M | 158279.00M | 137913.00M |
Total stockholder equity | 71015.00M | 75075.00M | 69389.00M | 63864.00M | 58225.00M |
Deferred long term liab | 3880.00M | 6270.00M | 6794.00M | 7294.00M | 7677.00M |
Other current liab | 47562.00M | 5604.00M | 5827.00M | 4821.00M | 4876.00M |
Common stock | 48193.00M | 47377.00M | 46513.00M | 45972.00M | 45440.00M |
Capital stock | 48193.00M | 47377.00M | 46513.00M | 45972.00M | 45440.00M |
Retained earnings | 56145.00M | 54906.00M | 49640.00M | 45108.00M | 40911.00M |
Other liab | 19948.00M | 19663.00M | 21033.00M | 21351.00M | 22460.00M |
Good will | 78150.00M | 79121.00M | 79552.00M | 79749.00M | 78678.00M |
Other assets | 7604.00M | 9801.00M | 51046.00M | 9059.00M | 8930.00M |
Cash | 12945.00M | 9408.00M | 7854.00M | 5683.00M | 4059.00M |
Cash and equivalents | 12945.00M | 9408.00M | 7854.00M | 5683.00M | 4059.00M |
Total current liabilities | 69736.00M | 67807.00M | 62017.00M | 53303.00M | 44009.00M |
Current deferred revenue | 3880.00M | 43808.00M | 37974.00M | 32613.00M | 28223.00M |
Net debt | 57787.00M | 66591.00M | 77188.00M | 83319.00M | 69370.00M |
Short term debt | 3456.00M | 5851.00M | 7078.00M | 5377.00M | 1985.00M |
Short long term debt | 1778.00M | 4205.00M | 5440.00M | 3781.00M | 1985.00M |
Short long term debt total | 70732.00M | 75999.00M | 85042.00M | 89002.00M | 73429.00M |
Other stockholder equity | -31858.00000M | -28173.00000M | -28178.00000M | -28235.00000M | -28228.00000M |
Property plant equipment | 12873.00M | 12896.00M | 12606.00M | 32904.00M | 11349.00M |
Total current assets | 65682.00M | 60008.00M | 56369.00M | 50302.00M | 45243.00M |
Long term investments | 21096.00M | 23025.00M | 20812.00M | 17314.00M | 15732.00M |
Net tangible assets | 71015.00M | -33072.00000M | -41305.00000M | -49006.00000M | -56977.00000M |
Short term investments | 2778.00M | 3117.00M | 3000.00M | 2373.00M | 2522.00M |
Net receivables | 27276.00M | 24431.00M | 21742.00M | 19617.00M | 17631.00M |
Long term debt | 50476.00M | 51971.00M | 59207.00M | 64699.00M | 71444.00M |
Inventory | 19090.00M | 17760.00M | 18496.00M | 17516.00M | 16450.00M |
Accounts payable | 14838.00M | 12544.00M | 11138.00M | 10492.00M | 8925.00M |
Total permanent equity | - | - | - | - | - |
Noncontrolling interest in consolidated entity | 300.00M | 306.00M | 312.00M | 306.00M | 318.00M |
Temporary equity redeemable noncontrolling interests | - | - | - | - | - |
Accumulated other comprehensive income | -1465.00000M | 965.00M | 1414.00M | 1019.00M | 102.00M |
Additional paid in capital | - | - | - | - | - |
Common stock total equity | 48193.00M | 47377.00M | 46513.00M | 45972.00M | 45440.00M |
Preferred stock total equity | - | - | - | - | - |
Retained earnings total equity | 56145.00M | 54906.00M | 49640.00M | 45108.00M | 40911.00M |
Treasury stock | -31858.00000M | -28173.00000M | -28178.00000M | -28235.00000M | -28228.00000M |
Accumulated amortization | - | - | - | - | - |
Non currrent assets other | 3968.00M | 4714.00M | 4624.00M | 4600.00M | 5046.00M |
Deferred long term asset charges | - | - | - | - | - |
Non current assets total | 162593.00M | 172991.00M | 174346.00M | 172147.00M | 151213.00M |
Capital lease obligations | 18478.00M | 19823.00M | 20395.00M | 20522.00M | - |
Long term debt total | 50476.00M | 51971.00M | 59207.00M | 64699.00M | 71444.00M |
Breakdown | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
---|---|---|---|---|---|
Type | yearly | yearly | yearly | yearly | yearly |
Date | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
Investments | -1017.00000M | -2717.00000M | -3172.00000M | -485.00000M | 125.00M |
Change to liabilities | 4260.00M | 5919.00M | 5278.00M | 3550.00M | 2183.00M |
Total cashflows from investing activities | -5047.00000M | -5261.00000M | -5534.00000M | -3339.00000M | -43285.00000M |
Net borrowings | -4211.00000M | -9267.00000M | -5673.00000M | -5320.00000M | 38265.00M |
Total cash from financing activities | -10516.00000M | -11356.00000M | -8155.00000M | -7850.00000M | 36819.00M |
Change to operating activities | 7149.00M | 3018.00M | 2873.00M | 1182.00M | -149.00000M |
Net income | 4165.00M | 7898.00M | 7192.00M | 6631.00M | -596.00000M |
Change in cash | 614.00M | 1648.00M | 2176.00M | 1659.00M | 2395.00M |
Begin period cash flow | 12691.00M | 11043.00M | 5954.00M | 4295.00M | 1900.00M |
End period cash flow | 13305.00M | 12691.00M | 8130.00M | 5954.00M | 4295.00M |
Total cash from operating activities | 16177.00M | 18265.00M | 15865.00M | 12848.00M | 8865.00M |
Issuance of capital stock | - | - | - | - | - |
Depreciation | 4247.00M | 4512.00M | 4441.00M | 4371.00M | 2718.00M |
Other cashflows from investing activities | -1303.00000M | -24.00000M | 75.00M | -397.00000M | -41373.00000M |
Dividends paid | 2907.00M | 2625.00M | 2624.00M | 2603.00M | 2038.00M |
Change to inventory | -1435.00000M | 735.00M | -973.00000M | -1075.00000M | -1153.00000M |
Change to account receivables | -2971.00000M | -2703.00000M | -1510.00000M | -2158.00000M | -1139.00000M |
Sale purchase of stock | -3500.00000M | 549.00M | 257.00M | 185.00M | 688.00M |
Other cashflows from financing activities | -449.00000M | 1523.00M | 10100.00M | 3809.00M | 44935.00M |
Change to netincome | 2533.00M | 549.00M | 1073.00M | 453.00M | 6855.00M |
Capital expenditures | 2727.00M | 2520.00M | 2437.00M | 2457.00M | 2037.00M |
Change receivables | 2971.00M | -2703.00000M | -1510.00000M | 2158.00M | -1139.00000M |
Cash flows other operating | 16177.00M | 1355.00M | 364.00M | 12848.00M | -3.00000M |
Exchange rate changes | - | - | - | - | - |
Cash and cash equivalents changes | 614.00M | 1648.00M | 2176.00M | 1659.00M | 2399.00M |
Change in working capital | 7003.00M | 3948.00M | 3159.00M | 1499.00M | -112.00000M |
Stock based compensation | 447.00M | 484.00M | 400.00M | 453.00M | 280.00M |
Other non cash items | 2390.00M | 1851.00M | 1243.00M | 548.00M | 6488.00M |
Free cash flow | 13450.00M | 15745.00M | 13428.00M | 10391.00M | 6828.00M |
Sector: Healthcare Industry: Healthcare Plans
Company | Change (USD) | Price (USD) | Trailing PE (x) | Forward PE (x) | Price Sales TTM (x) | Price to Book Value (x) | Enterprise Value to Revenue (x) | Enterprise Value to EBITDA (x) |
---|---|---|---|---|---|---|---|---|
CVS CVS Health Corp |
-0.71 0.90% | 78.27 | 12.06 | 9.08 | 0.29 | 1.34 | 0.47 | 8.96 |
UNH UnitedHealth Group Incorporated |
-2.54 0.51% | 491.69 | 22.57 | 18.38 | 1.33 | 5.65 | 1.38 | 13.97 |
ELV Elevance Health Inc |
0.37 0.07% | 514.67 | 18.00 | 12.66 | 0.65 | 2.87 | 0.74 | |
CI Cigna Corp |
-0.11 0.03% | 353.72 | 16.80 | 10.45 | 0.46 | 1.90 | 0.58 | |
HUM Humana Inc |
-0.8 0.23% | 347.39 | 19.16 | 14.60 | 0.56 | 3.37 | 0.53 |
CVS Health Corporation provides health services in the United States. It operates through Health Care Benefits, Pharmacy Services, and Retail/LTC segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. The Pharmacy Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, mail order pharmacy, specialty pharmacy and infusion, clinical, and disease and medical spend management services. It serves employers, insurance companies, unions, government employee groups, health plans, prescription drug plans, Medicaid managed care plans, plans offered on public health insurance and private health insurance exchanges, other sponsors of health benefit plans, and individuals. This segment operates retail specialty pharmacy stores; and specialty mail-order, mail-order dispensing, and compounding pharmacies, as well as branches for infusion and enteral nutrition services. The Retail/LTC segment sells prescription and over-the-counter drugs, consumer health and beauty products, and personal care products; and provides health care services through its MinuteClinic walk-in medical clinics. This segment also distributes prescription drugs; and provides related pharmacy consulting and other ancillary services to care facilities and other care settings. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was incorporated in 1996 and is headquartered in Woonsocket, Rhode Island.
One CVS Drive, Woonsocket, RI, United States, 02895
Name | Title | Year Born |
---|---|---|
Ms. Karen Sue Lynch | Pres, CEO & Director | 1963 |
Mr. Shawn Michael Guertin | Exec. VP & CFO | 1964 |
Dr. Alan M. Lotvin M.D. | Exec. VP & Pres of Pharmacy Services | 1962 |
Mr. James David Clark | Sr. VP, Controller & Chief Accounting Officer | 1965 |
Mr. Tilak Mandadi | Exec. VP & Chief Data, Digital and Technology Officer | 1964 |
Mr. Larry McGrath | Sr. VP of Bus. Devel. & Investor Relations | NA |
Mr. Thomas Michael Moriarty | Exec. VP, Chief Policy & External Affairs Officer and Gen. Counsel | 1964 |
Mr. David A. Falkowski | Exec. VP & Chief Compliance Officer | NA |
Mr. Norman de Greve | Chief Marketing Officer | NA |
Ms. Laurie P. Havanec | Exec. VP & Chief People Officer | 1961 |
Disclaimer - Data Powered by EOD Historical Data (“EODHD”). All CFDs (stocks, indices, mutual funds, ETFs), and Forex are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. EODHD is not using exchanges data feeds for the pricing data, EODHD is using OTC, peer to peer trades and trading platforms over 100+ sources, EODHD is aggregating its data feeds via VWAP method. Therefore, EOD Historical Data doesn’t bear any responsibility for any trading losses you might incur as a result of using this data. EOD Historical Data or anyone involved with EOD Historical Data will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible. EOD Historical Data does not give any warranties (including, without limitation, as to merchantability or fitness for a particular purpose or use).